APA (7th ed.) Citation

R, T., F, S., DJ, G., B, T., JL, B., MS, C., . . . ND, S. (2024). Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study. European urology oncology, 7(4), 906. https://doi.org/10.1016/j.euo.2023.11.024

Chicago Style (17th ed.) Citation

R, Tutrone, et al. "Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study." European Urology Oncology 7, no. 4 (2024): 906. https://doi.org/10.1016/j.euo.2023.11.024.

MLA (9th ed.) Citation

R, Tutrone, et al. "Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study." European Urology Oncology, vol. 7, no. 4, 2024, p. 906, https://doi.org/10.1016/j.euo.2023.11.024.